UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers

Breast cancer research and treatment, 2012-01, Vol.131 (1), p.41-48

2012

Volltextzugriff (PDF)

Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer

Annals of oncology, 2015-07, Vol.26 (7), p.1346-1352

2015

Volltextzugriff (PDF)

Impact of clinical, morphologic and molecular characteristics on response to neoadjuvant systemic therapy (NAST) in metaplastic breast cancer (MpBC)

Annals of oncology, 2018-10, Vol.29, p.viii73-viii74

2018

Volltextzugriff (PDF)

Loss of myoepithelium is variable in solid papillary carcinoma of the breast

Histopathology, 2007-11, Vol.51 (5), p.657-665

2007

Volltextzugriff (PDF)

Anatomy, Imaging, and Pathologic Conditions of the Brachial Plexus

Radiographics, 2020-10, Vol.40 (6), p.1686-1714

2020

Volltextzugriff (PDF)

1871 Inhibition of mTOR in combination with chemotherapy and angiogenic blockade shows activity in metaplastic breast cancer, an aggressive, chemo-refractory subtype of triple-negative breast cancer (TNBC)

European journal of cancer (1990), 2015-09, Vol.51, p.S289-S290

2015

Volltextzugriff (PDF)

Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: A histopathologic and immunohistochemical comparison

Human pathology, 1998-12, Vol.29 (12), p.1451-1456

1998

Volltextzugriff (PDF)

Somatic von hippel-lindau mutation in clear cell papillary cystadenoma of the epididymis

Human pathology, 1995-12, Vol.26 (12), p.1341-1346

1995

Volltextzugriff (PDF)

Correlation of very late activation integrin and CD44 expression with extrarenal invasion and metastasis of renal cell carcinomas

Human pathology, 1996-12, Vol.27 (12), p.1355-1360

1996

Volltextzugriff (PDF)

Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence

Cancer, 1999-12, Vol.86 (11), p.2320-2326

1999

Volltextzugriff (PDF)

Abstract P3-07-01: Towards a therapeutically relevant subtyping scheme for triple-negative breast cancer (TNBC), profiling results from A Randomized, TNBC Enrolling trial to confirm Molecular profiling Improves Survival (ARTEMIS)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-07-01

2019

Volltextzugriff (PDF)

Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer

International journal of cancer, 2003-01, Vol.103 (2), p.153-160

2003

Volltextzugriff (PDF)

Reliability of chromogenic in situ hybridization for detecting HER-2 gene status in breast cancer: comparison with fluorescence in situ hybridization and assessment of interobserver reproducibility

Modern pathology, 2005-08, Vol.18 (8), p.1015-1021

2005

Volltextzugriff (PDF)

Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2-neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer

Clinical cancer research, 2004-01, Vol.10 (1), p.136-143

2004

Volltextzugriff (PDF)

Expression of protease-activated receptor 1 in oral squamous cell carcinoma

Cancer letters, 2001-08, Vol.169 (2), p.173-180

2001

Volltextzugriff (PDF)

Aberrant Methylation of the Adenomatous Polyposis Coli (APC) Gene Promoter 1A in Breast and Lung Carcinomas

Clinical cancer research, 2001-07, Vol.7 (7), p.1998-2004

2001

Volltextzugriff (PDF)

Salivary duct carcinoma : Is a specific diagnosis possible by fine needle aspiration cytology?

Acta cytologica, 1998-11, Vol.42 (6), p.1389-1396

1998

Volltextzugriff (PDF)

Abstract OT2-01-14: Triple-negative first-line study: Neoadjuvant trial of nab-paclitaxel and atezolizumab, a PD-L1 inhibitor, in patients with triple negative breast cancer (TNBC) (NCT02530489)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.OT2-01-14-OT2-01-14

2017

Volltextzugriff (PDF)

Abstract P5-16-30: Feasibility trial for identification of patients for eliminating breast cancer surgery following neoadjuvant systemic therapy

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P5-P5-16-30

2017

Volltextzugriff (PDF)

DNA methylation profiles of lung tumors

Molecular cancer therapeutics, 2001-11, Vol.1 (1), p.61-67

2001

Volltextzugriff (PDF)

Abstract OT2-01-20: Phase IIB study of neoadjuvant panitumumab combined with carboplatin and paclitaxel (PaCT) for anthracycline-resistant triple-negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.OT2-01-20-OT2-01-20

2017

Volltextzugriff (PDF)

Minimal residual cancer

The American journal of surgical pathology, 1997-12, Vol.21 (12), p.1524-1525

Gilcrease, M Z

1997

Volltextzugriff (PDF)

Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas

Cancer research (Chicago, Ill.), 2001-06, Vol.61 (11), p.4556-4560

2001

Volltextzugriff (PDF)

Fine-needle aspiration of basaloid squamous carcinoma: A case report with review of differential diagnostic considerations

Diagnostic cytopathology, 1998-09, Vol.19 (3), p.210-215

1998

Volltextzugriff (PDF)

Abstract P3-14-02: Targeting the PI3K/AKT/mTOR pathway for the treatment of mesenchymal triple-negative breast cancer (TNBC): Evidence of efficacy and proof of concept from a phase I trial with dose expansion of mTOR inhibition in combination with liposomal doxorubicin and bevacizumab

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-14-02

2016

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Englisch
(135)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers

Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer

Impact of clinical, morphologic and molecular characteristics on response to neoadjuvant systemic therapy (NAST) in metaplastic breast cancer (MpBC)

Loss of myoepithelium is variable in solid papillary carcinoma of the breast

Anatomy, Imaging, and Pathologic Conditions of the Brachial Plexus

1871 Inhibition of mTOR in combination with chemotherapy and angiogenic blockade shows activity in metaplastic breast cancer, an aggressive, chemo-refractory subtype of triple-negative breast cancer (TNBC)

Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: A histopathologic and immunohistochemical comparison

Somatic von hippel-lindau mutation in clear cell papillary cystadenoma of the epididymis

Correlation of very late activation integrin and CD44 expression with extrarenal invasion and metastasis of renal cell carcinomas

Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence

Abstract P3-07-01: Towards a therapeutically relevant subtyping scheme for triple-negative breast cancer (TNBC), profiling results from A Randomized, TNBC Enrolling trial to confirm Molecular profiling Improves Survival (ARTEMIS)

Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer

Reliability of chromogenic in situ hybridization for detecting HER-2 gene status in breast cancer: comparison with fluorescence in situ hybridization and assessment of interobserver reproducibility

Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2-neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer

Expression of protease-activated receptor 1 in oral squamous cell carcinoma

Aberrant Methylation of the Adenomatous Polyposis Coli (APC) Gene Promoter 1A in Breast and Lung Carcinomas

Salivary duct carcinoma : Is a specific diagnosis possible by fine needle aspiration cytology?

Abstract OT2-01-14: Triple-negative first-line study: Neoadjuvant trial of nab-paclitaxel and atezolizumab, a PD-L1 inhibitor, in patients with triple negative breast cancer (TNBC) (NCT02530489)

Abstract P5-16-30: Feasibility trial for identification of patients for eliminating breast cancer surgery following neoadjuvant systemic therapy

DNA methylation profiles of lung tumors

Abstract OT2-01-20: Phase IIB study of neoadjuvant panitumumab combined with carboplatin and paclitaxel (PaCT) for anthracycline-resistant triple-negative breast cancer (TNBC)

Minimal residual cancer

Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas

Fine-needle aspiration of basaloid squamous carcinoma: A case report with review of differential diagnostic considerations

Abstract P3-14-02: Targeting the PI3K/AKT/mTOR pathway for the treatment of mesenchymal triple-negative breast cancer (TNBC): Evidence of efficacy and proof of concept from a phase I trial with dose expansion of mTOR inhibition in combination with liposomal doxorubicin and bevacizumab

Suchergebnisse filtern